ATE185973T1 - Verwendung von humanem atrio-natriuretischem peptid zur herstellung eines medikaments zur behandlung des atemunwohlseinsyndroms bei erwachsenen - Google Patents

Verwendung von humanem atrio-natriuretischem peptid zur herstellung eines medikaments zur behandlung des atemunwohlseinsyndroms bei erwachsenen

Info

Publication number: ATE185973T1
Authority: AT; Austria
Prior art keywords: treatment; natriuretic peptide; human; syndrome; unason
Prior art date: 1992-01-09

Application number

AT93100032T

Other languages

English (en)

Inventor

Masakazu Toutate New Hait Ueda

Original Assignee

Suntory Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-01-09

Filing date

1993-01-04

Publication date

1999-11-15

1993-01-04 Application filed by Suntory Ltd filed Critical Suntory Ltd

1999-11-15 Application granted granted Critical

1999-11-15 Publication of ATE185973T1 publication Critical patent/ATE185973T1/de

Links

239000003814 drug Substances 0.000 title abstract 2
229940079593 drug Drugs 0.000 title 1
239000000692 natriuretic peptide Substances 0.000 title 1
230000000241 respiratory effect Effects 0.000 title 1
208000011580 syndromic disease Diseases 0.000 title 1
206010001052 Acute respiratory distress syndrome Diseases 0.000 abstract 3
208000013616 Respiratory Distress Syndrome Diseases 0.000 abstract 3
208000011341 adult acute respiratory distress syndrome Diseases 0.000 abstract 3
201000000028 adult respiratory distress syndrome Diseases 0.000 abstract 3
101500027325 Homo sapiens Atrial natriuretic peptide Proteins 0.000 abstract 1
NSQLIUXCMFBZME-MPVJKSABSA-N carperitide Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 NSQLIUXCMFBZME-MPVJKSABSA-N 0.000 abstract 1
229950008486 carperitide Drugs 0.000 abstract 1
239000004615 ingredient Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Cardiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

AT93100032T 1992-01-09 1993-01-04 Verwendung von humanem atrio-natriuretischem peptid zur herstellung eines medikaments zur behandlung des atemunwohlseinsyndroms bei erwachsenen ATE185973T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP4002424A JP2925391B2 (ja)	1992-01-09	1992-01-09	Ａｒｄｓ治療用医薬組成物

Publications (1)

Publication Number	Publication Date
ATE185973T1 true ATE185973T1 (de)	1999-11-15

Family

ID=11528876

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93100032T ATE185973T1 (de)	1992-01-09	1993-01-04	Verwendung von humanem atrio-natriuretischem peptid zur herstellung eines medikaments zur behandlung des atemunwohlseinsyndroms bei erwachsenen

Country Status (8)

Country	Link
US (1)	US5418219A (de)
EP (1)	EP0551077B1 (de)
JP (1)	JP2925391B2 (de)
AT (1)	ATE185973T1 (de)
DE (1)	DE69326849T2 (de)
DK (1)	DK0551077T3 (de)
ES (1)	ES2141116T3 (de)
GR (1)	GR3032442T3 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6525022B1 (en)	1993-11-12	2003-02-25	Genentech, Inc.	Receptor specific atrial natriuretic peptides
US5665704A (en) *	1993-11-12	1997-09-09	Genentech, Inc.	Receptor specific atrial natriuretic peptides
US5846932A (en) *	1993-11-12	1998-12-08	Genentech, Inc.	Receptor specific atrial natriuretic peptides
US5504111A (en) *	1994-12-30	1996-04-02	Medichem Research, Inc.	Use of 2,3 alkylcarbonyloxybenzoic acid in treating adult respiratory distress syndrome
US5780440A (en) *	1996-06-17	1998-07-14	Protease Sciences Inc.	Treatment of pulmonary disease with protease inhibitors
CA2647018A1 (en)	1999-12-28	2001-07-05	Sony Corporation	Signal processing device and method, and recording medium
IL145926A0 (en) *	2001-10-15	2002-07-25	Mor Research Applic Ltd	Peptide epitopes of mimotopes useful in immunomodulation
IL155136A0 (en)	2003-02-10	2003-10-31	Enzymotec Ltd	A composition for reducing blood cholesterol and triglycerides
US20060233863A1 (en)	2003-02-10	2006-10-19	Enzymotec Ltd.	Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
BRPI0411410A (pt) *	2003-06-13	2006-07-25	Daiichi Asubio Pharma Co Ltd	composições farmacêuticas para a prevenção ou tratamento de doenças imunes mediadas por th1
CN101035594B (zh) *	2004-08-09	2013-10-23	酶学技术有限公司	用于糖尿病患者的食品
WO2006016363A2 (en)	2004-08-10	2006-02-16	Enzymotec Ltd.	Mixture of phytosterol ester(s) and 1, 3-diglyceride(s) for use in the treatment of medical conditions
EP1896500A4 (de) *	2005-06-28	2010-08-11	Yeda Res & Dev	Gliomedin, fragmente davon und verfahren zu ihrer anwendung
WO2007030492A2 (en) *	2005-09-06	2007-03-15	Guilford F Timothy	Method for the treatment of infection with hhv-6 virus and the amelioration of symptoms related to virus using liposomal encapsulation for delivery of reduced glutathione
KR101434612B1 (ko) *	2006-03-30	2014-08-26	팔라틴 테크놀로지스 인코포레이티드	사이클릭 나트륨 이뇨 펩타이드 구조물
US7795221B2 (en) *	2006-03-30	2010-09-14	Palatin Technologies, Inc.	Linear natriuretic peptide constructs
US8580746B2 (en) *	2006-03-30	2013-11-12	Palatin Technologies, Inc.	Amide linkage cyclic natriuretic peptide constructs
WO2008142693A2 (en) *	2007-05-22	2008-11-27	Yeda Research And Development Co. Ltd.	Regulation of myelination by nectin-like (necl) molecules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS60136596A (ja) *	1983-12-26	1985-07-20	Suntory Ltd	ペプチド及びこれを有効成分とする利尿剤
DE3443257A1 (de) *	1984-11-28	1986-05-28	Bissendorf Peptide GmbH, 3002 Wedemark	Mittel enthaltend vollsynthetisches alpha-humanes atriales natriuretisches peptid (alpha-hanap)
US5043321A (en)	1988-07-11	1991-08-27	Center For Innovative Technology	Adrenocorticotropin release inhibiting factor

1992
- 1992-01-09 JP JP4002424A patent/JP2925391B2/ja not_active Expired - Fee Related
1993
- 1993-01-04 DK DK93100032T patent/DK0551077T3/da active
- 1993-01-04 ES ES93100032T patent/ES2141116T3/es not_active Expired - Lifetime
- 1993-01-04 EP EP93100032A patent/EP0551077B1/de not_active Expired - Lifetime
- 1993-01-04 DE DE69326849T patent/DE69326849T2/de not_active Expired - Fee Related
- 1993-01-04 AT AT93100032T patent/ATE185973T1/de not_active IP Right Cessation
1994
- 1994-07-22 US US08/279,075 patent/US5418219A/en not_active Expired - Fee Related
2000
- 2000-01-20 GR GR20000400137T patent/GR3032442T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0551077B1 (de)	1999-10-27
DE69326849D1 (de)	1999-12-02
EP0551077A3 (en)	1994-06-29
ES2141116T3 (es)	2000-03-16
JPH05186366A (ja)	1993-07-27
GR3032442T3 (en)	2000-05-31
JP2925391B2 (ja)	1999-07-28
DK0551077T3 (da)	2000-04-10
US5418219A (en)	1995-05-23
DE69326849T2 (de)	2000-04-20
EP0551077A2 (de)	1993-07-14

Similar Documents

Publication	Publication Date	Title
ATE185973T1 (de)	1999-11-15	Verwendung von humanem atrio-natriuretischem peptid zur herstellung eines medikaments zur behandlung des atemunwohlseinsyndroms bei erwachsenen
ATE144142T1 (de)	1996-11-15	Verwendung von thiazolidin-4-carboxylatderivaten zur behandlung von lungenerkrankungen
UA35636C2 (uk)	2001-04-16	Поліпептид, який має активність легеневої поверхнево-активної речовини, та фармацевтична композиція для лікування респіраторного дистрес-синдрому у ссавців
ATE204178T1 (de)	2001-09-15	Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
ATE120644T1 (de)	1995-04-15	Verwendung von 1,3-oxathiolanalogen von nukleosiden zur herstellung eines arzneimittels zur behandlung von hepatitis-b.
ATE114113T1 (de)	1994-12-15	Verwendung von droloxifen bei der behandlung von knochenerkrankungen.
ATE179330T1 (de)	1999-05-15	Verbesserte alpha-interferon-zusammensetzung und verfahren zu ihrer herstellung aus leukocyten des menschlichen peripheren blute
DE69202207D1 (de)	1995-06-01	Verfahren zur Herstellung von 1-Chlor-1,1,3,3,3-Pentafluorpropan und von 1,1,1,3,3,3-Hexafluorpropan.
ATE206919T1 (de)	2001-11-15	Verwendung des wirkstoffs flupirtin zur herstellung eines arzneimittels zur bekämpfung von muskelverspannungen
DE3855113D1 (de)	1996-04-25	Verwendung von Buspiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung der Alkoholsucht
DE59000270D1 (de)	1992-10-01	Verwendung von mindestens ein cytokin zur herstellung eines arzneimittels zur systemischen behandlung von praeneoplastischen laesionen.
GR3026369T3 (en)	1998-06-30	Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist.
AT380202B (de)	1986-04-25	Material zur herstellung von artikeln zur abstuetzung des kopfes oder von gliedmassen des menschen oder von tieren, sowie aus diesem material hergestellte artikel
GR3025488T3 (en)	1998-02-27	Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions
DE69232911D1 (de)	2003-03-06	Verwendung eines polyhydroxybenzamids oder dessen Derivat zur Herstellung eines Medikaments für die Behandlung von viralen Infektionen
DE69122364D1 (de)	1996-10-31	Verwendung von (S)-Isofluran und (S)-Desfluran zur Anästhesie sowie entsprechende Arzneimittelzubereitungen
DK0443848T3 (da)	1994-10-17	Nyt antiulcermiddel
ATE247474T1 (de)	2003-09-15	Verwendung von inosittriphosphat zur herstellung von arzneimitteln
ATE194076T1 (de)	2000-07-15	Verwendung von n,s-diacetylcystein-ethylester (dacee) zur herstellung eines medikaments zur behandlung viraler erkrankungen
ATE235238T1 (de)	2003-04-15	Verwendung von 2,3- alkylcaebonyloxybenzoesäure zur behandlung des atemunwohlseinsydroms bei erwachsenen
ATE173629T1 (de)	1998-12-15	Hamamelis-trockenextrakt, verfahren zu seiner herstellung und seine verwendung als arzneimittel
ATE192650T1 (de)	2000-05-15	Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit
DE69632117D1 (de)	2004-05-13	Verwendung von 8,9-Dehydroestron zur Herstellung eines Arzneimittels zur Behandlung von durch freie Radikale verursachte Krankheiten
ATE121626T1 (de)	1995-05-15	Verwendung von 20(r)-22-oxa-vitamin d analoge zur herstellung eines medikaments für die behandlung des altershaut.
ATE124264T1 (de)	1995-07-15	Verwendung eines polypeptids mit humaner interleukin-2 aktivität zur herstellung pharmazeutischer zusammensetzungen zur behandlung von pneumothoraxen.

Legal Events

Date	Code	Title	Description
2004-03-15	EEIH	Change in the person of patent owner
2006-10-15	REN	Ceased due to non-payment of the annual fee